← Eichor
Study identifier: NCT06216756 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee

Condition: Osteochondral Defect  ·  Sponsor: AlloSource

PhaseNA
Planned participants68
Who can joinAll sexes, 12 Years to 60 Years
Healthy volunteersNo

About this study

The primary objective of this study is to obtain evidence of the effectiveness of Cryopreserved Osteochondral Allograft Core in the treatment of osteochondral lesions on the femoral condyle.

This description comes directly from the study's public registry record.

Talk to the study team

Elizabeth Esterl, DNP, MS, RN  ·  7207326231  ·  eesterl@allosource.org

Paige McHenry, MS, ATC, CCRA  ·  2154997062  ·  pmchenry@allosource.org

Always discuss trial participation with your own doctor first.

Locations (6)

Banner- University Medical Center- Phoenix Orthopedic and Sports Medicine InstitutePhoenix, Arizona, United StatesRecruiting
Cedars-Sinai Kerlan Jobe InstituteLos Angeles, California, United StatesNot Yet Recruiting
Stanford Medicine-Orthopaedics and Sports Medicine in Redwood CityRedwood City, California, United StatesRecruiting
University of California San FranciscoSan Francisco, California, United StatesRecruiting
Rush Copley Medical CenterAurora, Illinois, United StatesRecruiting
University of Kentucky Research FoundationLexington, Kentucky, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06216756